Pfizer Inc
PFE· NYSE
Released Feb 8, 2022, before the open
10-K filed Feb 24, 2022, 55 days after period end · 0000078003-22-000027
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | $16.19B | $11.43B | $1.84B | $1.16B |
| Net Income | $3.39B |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $846.00M |
| -$584.00M |
| -$394.00M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.